Form 8-K - Current report:
SEC Accession No. 0001787306-24-000090
Filing Date
2024-06-18
Accepted
2024-06-18 16:47:53
Documents
13
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20240614.htm   iXBRL 8-K 34448
  Complete submission text file 0001787306-24-000090.txt   161612

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240614.xsd EX-101.SCH 1889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240614_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240614_pre.xml EX-101.PRE 13038
16 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240614_htm.xml XML 2864
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 241052556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)